A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

NCT02278796 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse
Lymphoma, Follicular
Lymphoma, Mantle-Cell

Interventions

DRUG: BeEAM
DRUG: BEAM

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]